Your browser doesn't support javascript.
loading
Inhibition of malignant phenotypes of human osteosarcoma cells by a gene silencer, a pyrrole-imidazole polyamide, which targets an E-box motif.
Taniguchi, Masashi; Fujiwara, Kyoko; Nakai, Yuji; Ozaki, Toshinori; Koshikawa, Nobuko; Toshio, Kojima; Kataba, Motoaki; Oguni, Asako; Matsuda, Hiroyuki; Yoshida, Yukihiro; Tokuhashi, Yasuaki; Fukuda, Noboru; Ueno, Takahiro; Soma, Masayoshi; Nagase, Hiroki.
Afiliação
  • Taniguchi M; Division of Orthopedic Surgery, Nihon University School of Medicine, 30-1 Oyaguchi Kami-Cho, Itabashi, Tokyo 173-8610, Japan.
  • Fujiwara K; Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Japan ; Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan.
  • Nakai Y; Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan.
  • Ozaki T; Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Japan.
  • Koshikawa N; Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Japan.
  • Toshio K; Division of Orthopedic Surgery, Nihon University School of Medicine, 30-1 Oyaguchi Kami-Cho, Itabashi, Tokyo 173-8610, Japan.
  • Kataba M; Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Japan.
  • Oguni A; Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Japan.
  • Matsuda H; Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan.
  • Yoshida Y; Division of Orthopedic Surgery, Nihon University School of Medicine, 30-1 Oyaguchi Kami-Cho, Itabashi, Tokyo 173-8610, Japan.
  • Tokuhashi Y; Division of Orthopedic Surgery, Nihon University School of Medicine, 30-1 Oyaguchi Kami-Cho, Itabashi, Tokyo 173-8610, Japan.
  • Fukuda N; Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Japan ; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Japan.
  • Ueno T; Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Japan ; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Japan.
  • Soma M; Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Japan ; Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan.
  • Nagase H; Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Japan.
FEBS Open Bio ; 4: 328-34, 2014.
Article em En | MEDLINE | ID: mdl-24918046
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article